Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, Daniel·1993·Nature
DOI 10.1038/364362c0

Cited by (924)

Items 401–500 of 924

  1. Zinc amplifies mSOD1-mediated toxicity in a transgenic mouse model of amyotrophic lateral sclerosis
    Geert Jan Groeneveld, J. E. de Leeuw van Weenen, Freek L. Van Muiswinkel, H. Veldman, Jan Herman Veldink, John H. J. Wokke, Peter R. Bär, Leonard H. van den Berg · 2003 · Neuroscience Letters
  2. Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALS
    Paola Crociara, Maria Novella Chieppa, Elena Vallino Costassa, Elena Berrone, Marina Gallo, Monica Lo Faro, Maria Domenica Pintore, Barbara Iulini, Antonio D’Angelo, Giovanni E. Perona et al. · 2018 · Neurobiology of Disease
  3. Muscle Expression of SOD1G93A Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice
    Dobrowolny, Gabriella, Bernardini, Camilla, Martini, Martina, Baranzini, Mirko, Barba, Marta, Musarò, Antonio · 2015 · Frontiers in Cellular Neuroscience
  4. Critical analysis of translational potential of rodent models of white matter pathology across a wide spectrum of human diseases
    Wenxuan Zhou, Shiyue Xia, Chenmeng Wang, Qingwu Yang, Alexei Verkhratsky, Jianqin Niu · 2025 · Cell Death and Disease
  5. The Significance of 8-oxoGsn in Aging-Related Diseases
    Xinmu Zhang, Lin Li · 2020 · Aging and Disease
  6. Prionoids in amyotrophic lateral sclerosis
    Philippe Gosset, William Camu, Cédric Raoul, Alexandre Mezghrani · 2022 · Brain Communications
  7. Dietary intake of fruits and beta-carotene is negatively associated with amyotrophic lateral sclerosis risk in Koreans: A case-control study
    Youri Jin, Ki‐Wook Oh, Seong‐il Oh, Heejoon Baek, Seung Hyun Kim, Yongsoon Park · 2013 · Nutritional Neuroscience
  8. Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G93A ALS mice: overlapping effects or limited therapeutic opportunity?
    Renzo Mancuso, Jaume del Valle, Marta Morell, Mercè Pallàs, Rosario Osta, Xavier Navarro · 2014 · Orphanet Journal of Rare Diseases
  9. The Hitchhiker’s Guide to Nucleocytoplasmic Trafficking in Neurodegeneration
    Stephen R. Moore, Benjamin E. Rabichow, Rita Sattler · 2020 · Neurochemical Research
  10. The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement
    Sara Bachiller, Isabel María Alonso-Bellido, Luís Miguel Real, Eva M. Pérez-Villegas, Jose Luis Venero, Tomas Deierborg, Jose Angel Armengol, Rocío Ruiz · 2020 · International Journal of Molecular Sciences
  11. Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis
    Julien Praline, Hélène Blasco, Patrick Vourc’h, Valérian Rat, Chantal Gendrot, William Camu, Christian Robert Andres · 2012 · Journal of the Neurological Sciences
  12. Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity
    Shlomit Ezer, Muhannad Daana, Julien H. Park, Shira Yanovsky‐Dagan, Ulrika Nordström, Adily Basal, Simon Edvardson, Ann Saada, Markus Otto, Vardiella Meiner et al. · 2021 · Brain
  13. Normal complement of motor units in asymptomatic familial (SOD1 mutation) amyotrophic lateral sclerosis carriers
    Arun Kumar Aggarwal · 2001 · Journal of Neurology Neurosurgery & Psychiatry
  14. A seeded propagation of Cu, Zn-superoxide dismutase aggregates in amyotrophic lateral sclerosis
    Mariko Ogawa, Yoshiaki Furukawa · 2014 · Frontiers in Cellular Neuroscience
  15. Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis
    Yueqing Yang, Yong-Hui Zheng, Chun‐Ting Zhang, Weiwei Liang, Shuyu Wang, Xudong Wang, Ying Wang, Tianhang Wang, Hongquan Jiang, Honglin Feng · 2019 · Neurobiology of Disease
  16. Mitochondrial drug targets in neurodegenerative diseases
    Jiyoun Lee · 2016 · Bioorganic & Medicinal Chemistry Letters
  17. Pleiotropic activity of systemically delivered angiogenin in the SOD1G93A mouse model
    Martín Crivello, Saidhbhe L. O’Riordan, Ina Woods, Sarah Cannon, Luise Halang, Karen S. Coughlan, Marion C. Hogg, Sebastian A. Lewandowski, Jochen H.M. Prehn · 2018 · Neuropharmacology
  18. Characteristics of serum metabolites in sporadic amyotrophic lateral sclerosis patients based on gas chromatography-mass spectrometry
    Rui Jia, Qiao Yi Chen, Qingqing Zhou, Ronghua Zhang, Jiaoting Jin, Fangfang Hu, Xiao Liu, Xing Qin, Kang Li, Songzhen Zhao et al. · 2021 · Scientific Reports
  19. Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression
    Erica Tavazzi, Sebastian Daberdaku, Alessandro Zandonà, Rosario Vasta, Beatrice Nefussy, Christian Lunetta, Gabriele Mora, Jessica Mandrioli, Enrico Grisan, Claudia Tarlarini et al. · 2022 · Journal of Neurology
  20. Two Approaches to Drug Discovery in SOD1-Mediated ALS
    Wendy J. Broom, Kristen E. Auwarter, Jake Ni, Deborah E. Russel, Li-An Yeh, Michele M. Maxwell, Marcie A. Glicksman, Aleksey G. Kazantsev, Robert H. Brown · 2006 · SLAS DISCOVERY
  21. Transcriptome Profiling Following Neuronal and Glial Expression of ALS-Linked SOD1 inDrosophila
    Emily L. Kumimoto, Taylor R. Fore, Bing Zhang · 2013 · G3 Genes Genomes Genetics
  22. The relationship between parkin and protein aggregation in neurodegenerative diseases
    Preeti J. Khandelwal · 2010 · Frontiers in Psychiatry
  23. Probing protein aggregation using discrete molecular dynamics
    Shantanu K. Sharma · 2008 · Frontiers in bioscience
  24. Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse
    Paolo Bigini, Mariaelena Repici, Giuseppina Cantarella, Elena R. Fumagalli, Sara Barbera, Alfredo Cagnotto, Ada De Luigi, Rossella Tonelli, Renato Bernardini, Tiziana Borsello et al. · 2007 · Neurobiology of Disease
  25. The "new" mitochondrial disorders
    Anthony H.V. Schapira · 2002 · Journal of Neurology Neurosurgery & Psychiatry
  26. Neuroprotective Effect of a Multistrain Probiotic Mixture in SOD1G93A Mice by Reducing SOD1 Aggregation and Targeting the Microbiota-Gut-Brain Axis
    Zikai Xin, Cheng Xin, Jia Huo, Qi Liu, Hui Dong, Rui Li, Yaling Liu · 2024 · Molecular Neurobiology
  27. Amyotrophic Lateral Sclerosis: Drug Therapy from the Bench to the Bedside
    Mark B. Bromberg, Summer B. Gibson · 2012 · Seminars in Neurology
  28. Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
    Angelo C. Lepore · 2011 · Journal of Visualized Experiments
  29. Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis
    Michael A. van Es, Paul W.J. van Vught, Jan Herman Veldink, Peter Munch Andersen, Anna Birve, Robin Lemmens, Simon Cronin, Anneke J. van der Kooi, Marianne de Visser, Helenius Jurgen Schelhaas et al. · 2009 · Amyotrophic Lateral Sclerosis
  30. Synchrotron-based infrared spectroscopy brings to light the structure of protein aggregates in neurodegenerative diseases
    Guylaine Hoffner, William André, Christophe Sandt, Philippe Djian · 2014 · Reviews in Analytical Chemistry
  31. Embryonic Exposure to the Environmental Neurotoxin BMAA Negatively Impacts Early Neuronal Development and Progression of Neurodegeneration in the Sod1-G93R Zebrafish Model of Amyotrophic Lateral Sclerosis
    Samantha Powers, Samantha F. Kwok, Emily Lovejoy, Tom Lavin, Roger B. Sher · 2017 · Toxicological Sciences
  32. A Manganese Superoxide Dismutase (SOD2) Gene Polymorphism in Insulin‐Dependent Diabetes Mellitus
    Flemming Pociot, Tove Lorenzen, Jørn Nerup · 1993 · Disease Markers
  33. Protective Role of Lactobacillus rhamnosus Probiotic in Reversing Cocaine-Induced Oxidative Stress, Glial Activation and Locomotion in Mice
    Ernest T. Chivero, Susmita Sil, Seema Singh, Annadurai Thangaraj, Lila Gordon, Grace Evah-Nzoughe, Natasha Ferguson, Shannon E. Callen, Shilpa J. Buch · 2021 · Journal of Neuroimmune Pharmacology
  34. Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis
    Olmo Martín-Cámara, Marina Arribas, Geoffrey Wells, Marcos Morales-Tenorio, Ángeles Martín‐Requero, Gracia Porras, Ana Martı́nez, Giorgio Giorgi, Pilar López‐Alvarado, Isabel Lastres‐Becker et al. · 2022 · Journal of Medicinal Chemistry
  35. Modeling ALS and FTLD proteinopathies in yeast: An efficient approach for studying protein aggregation and toxicity
    Dmitry S. Kryndushkin, Frank P. Shewmaker · 2011 · Prion
  36. Exploration of Molecular Factors Impairing Superoxide Dismutase Isoforms Activity in Human Senile Cataractous Lenses
    Sankaranarayanan Rajkumar, Abhay Raghukant Vasavada, Mamidipudi R. Praveen, Ananthan Rajendran, G. Bhanuprakash Reddy, Harsha Tripathi, Darshini A Ganatra, Anshul I. Arora, Alpesh Ramanlal Patel · 2013 · Investigative Ophthalmology & Visual Science
  37. Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1G93A ALS mice
    Guillem Mòdol‐Caballero, Mireia Herrando‐Grabulosa, Belén García-Lareu, Neus Solanes, Sergi Verdés, Rosario Osta, Isaac Francos-Quijorna, Rubén López‐Vales, Ana Cristina Calvo, Assumpció Bosch et al. · 2020 · Neurobiology of Disease
  38. Ascending neuropathology in the CNS of a mutant SOD1 mouse model of amyotrophic lateral sclerosis
    Anna Leichsenring, Bettina Linnartz‐Gerlach, Xin‐Ran Zhu, Hermann Lübbert, Christine C. Stichel · 2006 · Brain Research
  39. Epothilone D accelerates disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
    Jayden A. Clark, Catherine A. Blizzard, Monique C. Breslin, Elise J. Yeaman, K. M. Lee, Jyoti A. Chuckowree, Tracey C. Dickson · 2018 · Neuropathology and Applied Neurobiology
  40. Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis
    Charlotte Veyrat‐Durebex, Philippe Corcia, Audrey Dangoumau, Frédéric Laumonnier, Éric Piver, P. H. Gordon, Christian Robert Andres, Patrick Vourc’h, Hélène Blasco · 2013 · Molecular Neurobiology
  41. Molecular Motor Proteins and Amyotrophic Lateral Sclerosis
    Kai Ying Soo, Manal A. Farg, Julie D. Atkin · 2011 · International Journal of Molecular Sciences
  42. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1G93A mouse model
    Eitan Lilo, Shane Wald-Altman, Leonardo J. Solmesky, Keren Ben‐Yaakov, Noga Gershoni‐Emek, Shlomo Bulvik, Ibrahim Kassis, Dimitrios M. Karussis, Eran Perlson, Miguel Weil · 2013 · Human Molecular Genetics
  43. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis
    Hongxia Lei, Elisabeth Dirren, Carole Poitry‐Yamate, Bernard Laurent Schneider, Rolf Gruetter A, Patrick Aebischer · 2018 · Journal of Cerebral Blood Flow & Metabolism
  44. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis
    Paula Korhonen, Eveliina Pollari, Katja M. Kanninen, Ekaterina Savchenko, Šárka Lehtonen, Sara Wojciechowski, Yuriy Pomeshchik, Ludo Van Den Bosch, Gundars Goldsteins, Jari Koıstınaho et al. · 2019 · IBRO Reports
  45. Amyotrophic Lateral Sclerosis
    J. Jefferson P. Perry, David S. Shin, John A. Tainer · 2010 · Advances in experimental medicine and biology
  46. Spinal Cord
    Kourosh Rezania, Raymond P. Roos · 2012 · Neurologic Clinics
  47. Unaffected motor endplate occupancy in eye muscles of ALS G93A mouse model
    Fátima Pedrosa Domellöf · 2012 · Frontiers in Bioscience-Scholar
  48. The proportion of mutations predicted to have a deleterious effect differs between gain and loss of function genes in neurodegenerative disease
    Paul N. Valdmanis, Dominique J. Verlaan, Guy Armand Rouleau · 2008 · Human Mutation
  49. Role of CNC1 gene in TDP-43 aggregation-induced oxidative stress-mediated cell death in S. cerevisiae model of ALS
    Vidhya Bharathi, Amandeep Girdhar, Basant Kumar Patel · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  50. Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation
    Karin Forsberg, Karin S. Graffmo, Erica Stenvall, Naima Tabikh, Stefan L. Marklund, Thomas Brännström, Peter Munch Andersen · 2022 · Acta Neuropathologica
  51. Recent Progress of Antisense Oligonucleotide Therapy for Superoxide-Dismutase-1-Mutated Amyotrophic Lateral Sclerosis: Focus on Tofersen
    Hidenori Moriyama, Toshifumi Yokota · 2024 · Genes
  52. Presymptomatic electrophysiological tests predict clinical onset and survival in SOD1G93A ALS mice
    Renzo Mancuso, Rosario Osta, Xavier Navarro · 2014 · Muscle & Nerve
  53. Expression of Microsomal Prostaglandin E Synthase-1 in the Spinal Cord in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
    Hiroko Miyagishi, Yasuhiro Kosuge, Kumiko Ishige, Yoshihisa Ito · 2012 · Journal of Pharmacological Sciences
  54. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis
    Jose A. Martinez, George J. Francis, W.Q. Liu, N. Pradzinsky, Jared M. Fine, M. Wilson, Leah R. Hanson, William H. Frey, Douglas William Zochodne, Tessa Gordon et al. · 2008 · Neuroscience · Retracted
  55. Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis
    Silvia Caioli, Livia Curcio, Massimo Pieri, Alessia Antonini, Roberta Marolda, Cinzia Severini, Cristina Zona · 2011 · Neurobiology of Disease
  56. RNA Dysregulation in Diseases of Motor Neurons
    Fadia Ibrahim, Tadashi Nakaya, Zissimos Mourelatos · 2011 · Annual Review of Pathology Mechanisms of Disease
  57. Membrane cholesterol depletion in cortical neurons highlights altered NMDA receptor functionality in a mouse model of amyotrophic lateral sclerosis
    Alessia Antonini, Silvia Caioli, Luana Saba, Giulia Vindigni, Silvia Biocca, Nadia Canu, Cristina Zona · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  58. Perturbations in intracellular Ca2+ handling in skeletal muscle in the G93A*SOD1 mouse model of amyotrophic lateral sclerosis
    Eva R. Chin, Dapeng Chen, Kostyantyn D. Bobyk, Davi A. G. Mázala · 2014 · American Journal of Physiology-Cell Physiology
  59. Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited
    Manuel José Rodríguez, Nicole Mahy · 2016 · Current Medicinal Chemistry
  60. The prion-like nature of amyotrophic lateral sclerosis
    Luke McAlary, Justin J. Yerbury, Neil R. Cashman · 2020 · Progress in molecular biology and translational science
  61. A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counseling
    Terrell E. Brotherton, Meraida A. Polak, Crystal Marie Kelly, Anna Birve, Peter Munch Andersen, Stefan L. Marklund, Jonathan D. Glass · 2010 · Amyotrophic Lateral Sclerosis
  62. Amyotrophic Lateral Sclerosis with IgM Antibody against Gangliosides GM2 and GD2
    Kotaro Mizutani, Nobuyuki Oka, Susumu Kusunoki, Ryuji Kaji, Masutaro Kanda, Ichiro Akiguchi, H. Shibasaki · 2003 · Internal Medicine
  63. Further development of biomarkers in amyotrophic lateral sclerosis
    Hélène Blasco, Patrick Vourc’h, Pierre‐François Pradat, P. H. Gordon, Christian Robert Andres, Philippe Corcia · 2016 · Expert Review of Molecular Diagnostics
  64. Neurodegenerative diseases: model organisms, pathology and autophagy
    Shwetha Suresh, Vijaya Verma, Shruthi Sateesh, James Premdoss Clement, Ravi R. Manjithaya · 2018 · Journal of Genetics
  65. Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges
    Annarita Miccio, Panagiotis Antoniou, Sorana Ciura, Edor Kabashi · 2021 · Molecular Therapy
  66. Two Potential Biomarkers Identified in Mesenchymal Stem Cells and Leukocytes of Patients with Sporadic Amyotrophic lateral Sclerosis
    Henny Nachmany, Shane Wald-Altman, Michal Abekasis, Shlomo Bulvik, Miguel Weil · 2012 · Disease Markers
  67. Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes
    Wendy J. Broom, Carsten Russ, Peter C. Sapp, Diane M. McKenna-Yasek, Betsy A. Hosler, Peter Munch Andersen, Robert H. Brown · 2005 · Neuroscience Letters
  68. Gene expression profile as a prognostic factor in high-grade gliomas
    Tomasz Czernicki, Jolanta Żegarska, Leszek Pączek, Božena Cukrowská, Wiesława Grajkowska, A. Zajączkowska, Kazimierz Brudzewski, J. Ulaczyk, Andrzej Marchel · 2007 · International Journal of Oncology
  69. Maternal Blood Glucose Levels Determine the Severity of Diabetic Embryopathy in Mice with Different Expression of Copper-Zinc Superoxide Dismutase (CuZnSOD)
    Sheller Zabihi, Parri Wentzel, Ulf J. Eriksson · 2008 · Toxicological Sciences
  70. FUS gene mutation in amyotrophic lateral sclerosis: a new case report and systematic review
    Xin Xiao, Min Li, Zhi Ye, Xiaoyan He, Jun Stephen Wei, Yunhong Zha · 2023 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  71. Nuclear pore dysfunction and disease: a complex opportunity
    Charlotte M. Fare, Jeffrey D. Rothstein · 2024 · Nucleus
  72. Points to Consider in the Clinical Use of NGS Panels for Mitochondrial Disease: An Analysis of Gene Inclusion and Consent Forms
    Julia Platt, Rachel Cox, Gregory M. Enns · 2014 · Journal of Genetic Counseling
  73. SOD1 dimerization monitoring using a novel split NanoLuc, NanoBit
    Kentaro Oh‐hashi, Yoko Hirata, Kazutoshi Kiuchi · 2016 · Cell Biochemistry and Function
  74. Micro-computed tomography for non-invasive evaluation of muscle atrophy in mouse models of disease
    Laura Pasetto, Davide Olivari, Giovanni Nardo, Maria Chiara Trolese, Caterina Bendotti, Rosanna Piccirillo, Valentina Bonetto · 2018 · PLoS ONE
  75. Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases
    Christine L. Péladeau, Jagdeep K. Sandhu · 2021 · International Journal of Molecular Sciences
  76. Gene Therapy for Rare Neurological Disorders
    Terence R. Flotte, Dominic J. Gessler · 2022 · Clinical Pharmacology & Therapeutics
  77. Solvent sensitivity of protein aggregation in Cu, Zn superoxide dismutase: a molecular dynamics simulation study
    Amresh Prakash, Vijay Kumar, Preeti Pandey, Deepak Ramkumar Bharti, Poonam Vishwakarma, Ruhar Singh, Md. Imtaiyaz Hassan, Andrew Michael Lynn · 2017 · Journal of Biomolecular Structure and Dynamics
  78. Calcium-influx increases SOD1 aggregates via nitric oxide in cultured motor neurons
    Hyunjung Kim, Wooseok Im, Seungchan Kim, Sung Hun Kim, Jung-Jun Sung, Manho Kim, Kwang Woo Lee · 2007 · Experimental & Molecular Medicine
  79. SOD1A4V-mediated ALS: Absence of a closely linked modifier gene and origination in Asia
    Wendy J. Broom, D.V. Johnson, Kristen E. Auwarter, Anthony John Iafrate, Carsten Russ, Ammar Al‐Chalabi, Peter C. Sapp, D. McKenna‐Yasek, Peter Munch Andersen, Robert H. Brown · 2007 · Neuroscience Letters
  80. Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
    Tingting Wen, Zhaohui Zhang · 2023 · Frontiers in Neuroscience
  81. Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis
    Yasuyuki Ohta, Genevieve Soucy, Daniel Phaneuf, Jean‐Nicolas Audet, François Gros‐Louis, Guy Armand Rouleau, Hélène Blasco, Philippe Corcia, Peter Munch Andersen, Frida Nordin et al. · 2016 · Human Molecular Genetics
  82. Functional Genomics of Axons and Synapses to Understand Neurodegenerative Diseases
    Andrés Di Paolo, Joaquín Garat, Guillermo Eastman, Joaquina Farías, Federico Dajas‐Bailador, Pablo Smircich, José Roberto Sotelo-Silveira · 2021 · Frontiers in Cellular Neuroscience
  83. Neurogenetics II: complex disorders
    Alan F. Wright · 2005 · Journal of Neurology Neurosurgery & Psychiatry
  84. Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
    Lina Yan, Yaling Liu, Can Sun, Qian Zheng, Pengli Hao, Jingxu Zhai, Yuanyuan Liu · 2018 · Medical Science Monitor
  85. A method comparison in monitoring disease progression of G93A mouse model of ALS
    Chang Zhou, Cuiping Zhao, Chen Zhang, G. Y. Wu, Fu Xiong, Zhang Cheng · 2007 · Amyotrophic Lateral Sclerosis
  86. Canine Motor Neuron Disease: Clinicopathologic Features and Selected Indicators of Oxidative Stress
    Sherril L. Green, Donna M. Bouley, Martin J. Pinter, Linda C. Cork, Govind T. Vatassery · 2001 · Journal of Veterinary Internal Medicine
  87. RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice
    Alexandra Weiss, James W. Gilbert, Iris Valeria Rivera Flores, Jillian Belgrad, Chantal M. Ferguson, Elif O. Dogan, Nicholas Wightman, Kit Mocarski, Dimas Echeverria, Ashley L. Harkins et al. · 2025 · Molecular Therapy
  88. Toxic SOD1 trimers are off-pathway in the formation of amyloid-like fibrils in ALS
    Brianna Hnath, Nikolay V. Dokholyan · 2022 · Biophysical Journal
  89. Inhibitory Effect of α-Tocopherol on Methylmercury-Induced Oxidative Steress
    Taro Yamashita, Yukio Ando, 中村政明, Konen Obayashi, Hisayasu Terazaki, Katsuki Haraoka, Sun Xu Guo, Mitsuharu Ueda, Makoto Uchino · 2004 · Environmental Health and Preventive Medicine
  90. Involvement of heterologous ubiquitination including linear ubiquitination in Alzheimer’s disease and amyotrophic lateral sclerosis
    Yusuke Sato, Seigo Terawaki, Daisuke Oikawa, Kouhei Shimizu, Yoshinori Okina, Hidefumi Ito, Fuminori Tokunaga · 2023 · Frontiers in Molecular Biosciences
  91. Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo
    Viktoriya G. Krut’, Andrei L. Kalinichenko, Dmitry I. Maltsev, David Jappy, Evgeny K. Shevchenko, Oleg V. Podgorny, Vsevolod Vadimovich Belousov · 2024 · Progress in Neurobiology
  92. A high-throughput screen to identify inhibitors of SOD1 transcription
    Paul D. Wright · 2012 · Frontiers in Bioscience-Elite
  93. Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS
    Ju-Hwang Park, Hang-Soo Park, Sunghoi Hong, Seongman Kang · 2016 · Experimental & Molecular Medicine
  94. Does Sporadic Amyotrophic Lateral Sclerosis Spread via Axonal Connectivities?
    Heiko Braak, Manuela Neumann, AC Ludolph, Kelly Del Tredici · 2017 · Neurology International Open
  95. Intrathecal Injection of scAAV9–hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway
    Haojie Hu, Huiqian Lin, WeiSong Duan, Can Cui, Zhongyao Li, Yakun Liu, Wan Wang, Di Wen, Ying Wang, Chunyan Li · 2018 · Neuroscience
  96. Human Bone Marrow-Derived Mesenchymal Stem Cell Applications in Neurodegenerative Disease Treatment and Integrated Omics Analysis for Successful Stem Cell Therapy
    Seok Gi Kim, Nimisha Pradeep George, Ji Su Hwang, Seokho Park, Myeong Ok Kim, Soo‐Hwan Lee, Gwang Lee · 2023 · Bioengineering
  97. Increased heart rate variability in mice overexpressing the Cu/Zn superoxide dismutase
    Jérôme Thireau, Denise Poisson, Bei Li Zhang, Ludovic Gillet, Marie LePecheur, Christian Robert Andres, Jacqueline London, Dominique Babuty · 2008 · Free Radical Biology and Medicine
  98. Beneficial Effects of the Free Radical Scavenger Edaravone (Radicut) in Neurologic Diseases
    Kiyoshi Kikuchi, Naoki Miura, Yoko Morimoto, Takashi Ito · 2011 · Journal of Neurology & Neurophysiology
  99. Protection Against Oxidative Stress and “IGF-I Deficiency Conditions”
    Úrsula Muñoz, Inma Castilla‐Cortázar · 2012 · InTech eBooks
  100. Elevation of serum soluble E-selectin and antisulfoglucuronyl paragloboside antibodies in amyotrophic lateral sclerosis
    J. Ikeda, Tatsuo Kohriyama, Sho Nakamura · 2000 · European Journal of Neurology